SCHEMBL5063473

SCHEMBL5063473

CNC(=O)c1ccc(C(=O)OC)c(Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.50
PYGL P06737 3/20 0.50
ALDH1A1 P00352 3/20 0.50
S1PR1 P21453 1/20 0.48
S1PR3 Q99500 1/20 0.48
MAPT P10636 5/20 0.47
KDM4E B2RXH2 2/20 0.47
GLA P06280 1/20 0.47
GAA P10253 1/20 0.47
CASP1 P29466 1/20 0.47
CASP7 P55210 1/20 0.47
ATM Q13315 1/20 0.47
HSD17B10 Q99714 1/20 0.47
PLK1 P53350 2/20 0.47
FLT1 P17948 1/20 0.47
FLT4 P35916 1/20 0.47
KDR P35968 1/20 0.47
ABL1 P00519 1/20 0.46
RAB9A P51151 2/20 0.45
CYP1A2 P05177 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3783986 0.86 PYGL (0.57) HPGDPYGLALDH1A1MAPTKDM4E
SCHEMBL69263 0.86 KDM4E (0.62) HPGDALDH1A1MAPTKDM4EGLA
SCHEMBL1483700 0.85 MAPT (0.59) HPGDALDH1A1S1PR1S1PR3MAPT
SCHEMBL2890548 0.84 KDM4E (0.51) HPGDALDH1A1S1PR1S1PR3MAPT
SCHEMBL29606273 0.83 TSHR (0.55) HPGDPYGLALDH1A1S1PR1S1PR3
SCHEMBL1483403 0.83 TSHR (0.55) HPGDPYGLALDH1A1S1PR1S1PR3
SCHEMBL16957205 0.83 KDM4E (0.50) HPGDALDH1A1S1PR1S1PR3MAPT
SCHEMBL12268010 0.83 KDM4E (0.50) HPGDALDH1A1MAPTKDM4EGLA
SCHEMBL6243384 0.83 KDM4E (0.50) HPGDALDH1A1S1PR1S1PR3MAPT
SCHEMBL3116280 0.83 MAPT (0.50) HPGDALDH1A1S1PR1S1PR3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080161294-A1 Urea derivative, medicinal composition containing the same, and medicinal use of these KISSEI PHARMACEUTICAL CO., LTD. (JP) 2008-07-03 US disclosed
US-20080161294-A1 Urea derivative, medicinal composition containing the same, and medicinal use of these KISSEI PHARMACEUTICAL CO., LTD. (JP) 2008-07-03 US disclosed
US-20080161294-A1 Urea derivative, medicinal composition containing the same, and medicinal use of these KISSEI PHARMACEUTICAL CO., LTD. (JP) 2008-07-03 US disclosed
EP-1867639-A1 UREA DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND MEDICINAL USE OF THESE Kissei Pharmaceutical Co., Ltd. (JP) 2007-12-19 EP disclosed
EP-1867639-A1 UREA DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND MEDICINAL USE OF THESE Kissei Pharmaceutical Co., Ltd. (JP) 2007-12-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161294-A1 Urea derivative, medicinal composition containing the same, and medicinal use of these AVPR2, UTS2R, GPR119 HPGD 599/4885PYGL 2847/4885ALDH1A1 1758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.